Stammdaten
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Unternehmen & Branche
| Name | Iterum Therapeutics plc |
|---|---|
| Ticker | ITRM |
| CIK | 0001659323 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | g6333l101 |
|---|---|
| ISIN | USG6333L1010 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,6 Mio. USD |
| Beta | 3,01 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-09-30 | 10-Q | 390,000 | -8,979,000 | -0.20 | 32,503,000 | -7,381,000 |
| 2025-06-30 | 10-Q | -6,509,000 | -0.16 | 34,014,000 | -3,887,000 | |
| 2025-03-31 | 10-Q | -4,891,000 | -0.14 | 32,975,000 | -2,554,000 | |
| 2024-12-31 | 10-K | -24,774,000 | -1.26 | 44,595,000 | -4,081,000 | |
| 2024-12-31 | 10-Q | -24,774,000 | 44,595,000 | -4,081,000 | ||
| 2024-09-30 | 10-Q | -6,094,000 | -0.30 | 15,924,000 | -11,507,000 | |
| 2024-06-30 | 10-Q | -4,997,000 | -0.30 | 14,174,000 | -10,913,000 | |
| 2024-03-31 | 10-Q | -7,101,000 | -0.46 | 19,625,000 | -6,150,000 | |
| 2023-12-31 | 10-K | -38,371,000 | -2.96 | 26,259,000 | -6,403,000 | |
| 2023-12-31 | 10-Q | -38,371,000 | 26,259,000 | -6,403,000 | ||
| 2023-09-30 | 10-Q | -3,877,000 | -0.30 | 39,728,000 | 3,432,000 | |
| 2023-06-30 | 10-Q | -12,243,000 | -0.95 | 51,021,000 | 7,129,000 | |
| 2023-03-31 | 10-Q | -9,889,000 | -0.78 | 58,120,000 | 18,957,000 | |
| 2022-12-31 | 10-Q | -44,434,000 | 66,833,000 | 27,999,000 | ||
| 2022-12-31 | 10-K | -44,434,000 | -3.63 | 66,833,000 | 27,999,000 | |
| 2022-09-30 | 10-Q | -29,109,000 | -2.38 | 71,555,000 | 32,549,000 | |
| 2022-06-30 | 10-Q | -6,735,000 | -0.55 | 76,687,000 | 43,886,000 | |
| 2022-03-31 | 10-Q | -3,500,000 | -0.29 | 84,063,000 | 48,635,000 | |
| 2021-12-31 | 10-K | 0 | -91,564,000 | -8.41 | 91,509,000 | 50,234,000 |
| 2021-12-31 | 10-Q | -91,564,000 | 91,509,000 | 50,234,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Apollon Financial, LLC | 630,250 | 0 | 630,250 | 211,134 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 289,410 | 0 | 289,410 | 96,952 | Neu | +100,0% | |
| UBS Group AG | 119,948 | 0 | 119,948 | 40,182 | Neu | +100,0% | |
| Gen-Wealth Partners Inc | 84,630 | 0 | 84,630 | 28,351 | Neu | +100,0% | |
| Krilogy Financial LLC | 40,000 | 0 | 40,000 | 13,420 | Neu | +100,0% | |
| Ground Swell Capital, LLC | 20,477 | 0 | 20,477 | 6,860 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 12,370 | 0 | 12,370 | 4,143 | Neu | +100,0% | |
| MORGAN STANLEY | 5,713 | 0 | 5,713 | 1,914 | Neu | +100,0% | |
| Activest Wealth Management | 133 | 0 | 133 | 45 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 85 | 0 | 85 | 28 | Neu | +100,0% | |
| Cypress Capital Management LLC (WY) | 66 | 0 | 66 | 22 | Neu | +100,0% | |
| BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 66 | 0 | 66 | 22 | Neu | +100,0% | |
| Virtu Financial LLC | 22,062 | 0 | 22,062 | 7 | Neu | +100,0% | |
| SBI Securities Co., Ltd. | 16 | 0 | 16 | 5 | Neu | +100,0% | |
| SG Americas Securities, LLC | 12,782 | 0 | 12,782 | 4 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| Apollon Financial, LLC | 630,250 | 211,134 | 52.38 |
| JANE STREET GROUP, LLC | 289,410 | 96,952 | 24.05 |
| UBS Group AG | 119,948 | 40,182 | 9.97 |
| Gen-Wealth Partners Inc | 84,630 | 28,351 | 7.03 |
| Krilogy Financial LLC | 40,000 | 13,420 | 3.33 |
| Ground Swell Capital, LLC | 20,477 | 6,860 | 1.70 |
| GEODE CAPITAL MANAGEMENT, LLC | 12,370 | 4,143 | 1.03 |
| MORGAN STANLEY | 5,713 | 1,914 | 0.47 |
| Activest Wealth Management | 133 | 45 | 0.01 |
| WELLS FARGO & COMPANY/MN | 85 | 28 | 0.01 |
| Cypress Capital Management LLC (WY) | 66 | 22 | 0.01 |
| BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 66 | 22 | 0.01 |
| Virtu Financial LLC | 22,062 | 7 | 0.00 |
| SBI Securities Co., Ltd. | 16 | 5 | 0.00 |
| SG Americas Securities, LLC | 12,782 | 4 | 0.00 |